What Happens When You Stop
Clinical trials provide clear data on what happens after stopping weight loss medication. The finding is consistent across drugs: weight regain is substantial and begins quickly. This is a biological response, not a failure of effort.
Quick read · 4 min
- •If you stop taking weight loss medication, you will likely regain most of the weight
- •In trials, people who stopped regained about two-thirds of their lost weight within a year
- •This isn't a willpower issue — your body's hormones actively push weight back up
- •Most experts now view obesity medication as a long-term treatment, not a short course
Based on clinical trials · No rankings · Every claim linked to source
Last reviewed: March 2026
What the trial data shows
People who stopped semaglutide regained approximately two-thirds of their prior weight loss within 1 year — without any change in behaviour.
The improvements in blood pressure, cholesterol, and blood sugar also went back toward where they started in those who regained weight.
Net difference between continuing and stopping: 14.8% body weight at 48 weeks.
Of those who stopped tirzepatide, about 8 in 10 people (82.5%) regained at least 25% of their initial weight loss within 1 year. Only about 1 in 6 (16.6%) of those who stopped managed to keep 80%+ of their weight loss, versus nearly 9 in 10 (89.5%) who continued treatment.
The improvements in blood pressure, cholesterol, and blood sugar also reversed in those who regained weight.
Why weight regain happens
This is not willpower failure. Weight regain after stopping treatment is your body's natural biological response — the same hormonal mechanisms that made sustained weight loss difficult in the first place.
When GLP-1 drugs are stopped, the appetite-suppressing effects end rapidly. Your body's hormonal state reverts:
- •Ghrelin (the hunger hormone) rises, increasing appetite
- •Leptin sensitivity decreases, reducing the effectiveness of the fullness signal
- •Metabolic rate returns to its pre-treatment baseline
- •Food cravings increase, making high-calorie foods harder to resist
What this means for treatment
The consistent evidence from these trials supports the view that GLP-1 drugs and similar medications are likely long-term — potentially lifelong — treatments for obesity, in the same way that blood pressure medications are not typically stopped once they are working.
This is an important factor in deciding whether to start: cost, access, side effects, and the long-term commitment required are ongoing considerations.